
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Current Status and Future Prospects for Esophageal Cancer
Mahdi Sheikh, Gholamreza Roshandel, Valerie McCormack, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 765-765
Open Access | Times Cited: 130
Mahdi Sheikh, Gholamreza Roshandel, Valerie McCormack, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 765-765
Open Access | Times Cited: 130
Showing 1-25 of 130 citing articles:
Precision Imaging for Early Detection of Esophageal Cancer
Po-Chun Yang, Chien‐Wei Huang, Riya Karmakar, et al.
Bioengineering (2025) Vol. 12, Iss. 1, pp. 90-90
Open Access | Times Cited: 1
Po-Chun Yang, Chien‐Wei Huang, Riya Karmakar, et al.
Bioengineering (2025) Vol. 12, Iss. 1, pp. 90-90
Open Access | Times Cited: 1
Hypoxia-induced SHMT2 protein lactylation facilitates glycolysis and stemness of esophageal cancer cells
Zhe Qiao, Yu Li, Shaomin Li, et al.
Molecular and Cellular Biochemistry (2024) Vol. 479, Iss. 11, pp. 3063-3076
Closed Access | Times Cited: 13
Zhe Qiao, Yu Li, Shaomin Li, et al.
Molecular and Cellular Biochemistry (2024) Vol. 479, Iss. 11, pp. 3063-3076
Closed Access | Times Cited: 13
Advancing Esophageal Cancer Treatment: Immunotherapy in Neoadjuvant and Adjuvant Settings
Daniel Park, Won Jin Jeon, Chieh Yang, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 318-318
Open Access | Times Cited: 10
Daniel Park, Won Jin Jeon, Chieh Yang, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 318-318
Open Access | Times Cited: 10
Age-period-cohort analysis of incidence, mortality and disability-adjusted life years of esophageal cancer in global, regional and national regions from 1990 to 2019
Huiying Li, Xianzhi Yang, Aiqi Zhang, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Huiying Li, Xianzhi Yang, Aiqi Zhang, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Cross Branch Co-Attention Network multimodal models based on Raman and FTIR spectroscopy for diagnosis of multiple selected cancers
Xuguang Zhou, Chen Chen, Enguang Zuo, et al.
Applied Soft Computing (2024) Vol. 166, pp. 112204-112204
Closed Access | Times Cited: 5
Xuguang Zhou, Chen Chen, Enguang Zuo, et al.
Applied Soft Computing (2024) Vol. 166, pp. 112204-112204
Closed Access | Times Cited: 5
DKK1 and Its Receptors in Esophageal Adenocarcinoma: A Promising Molecular Target
Markos Despotidis, Orestis Lyros, Tatiana S. Driva, et al.
Diagnostics (2025) Vol. 15, Iss. 1, pp. 85-85
Open Access
Markos Despotidis, Orestis Lyros, Tatiana S. Driva, et al.
Diagnostics (2025) Vol. 15, Iss. 1, pp. 85-85
Open Access
Immune-related adverse events not associated with survival in advanced or metastatic gastroesophageal cancers
Omar Elghawy, Reema Patel, Abhishek Mullapudi, et al.
Journal of Chemotherapy (2025), pp. 1-7
Closed Access
Omar Elghawy, Reema Patel, Abhishek Mullapudi, et al.
Journal of Chemotherapy (2025), pp. 1-7
Closed Access
Establishment of an Early Warning Screening System for High Risk Population in High Incidence Area of Esophageal Cancer, Gansu province, northwestern China: A Retrospective Population-Based Study
Duojie Zhu, Chengyun Li, Yinggang Che, et al.
Research Square (Research Square) (2025)
Closed Access
Duojie Zhu, Chengyun Li, Yinggang Che, et al.
Research Square (Research Square) (2025)
Closed Access
Exploring metabolic reprogramming in esophageal cancer: the role of key enzymes in glucose, amino acid, and nucleotide pathways and targeted therapies
Xue-Man Dong, Lin Chen, Yuxin Xu, et al.
Cancer Gene Therapy (2025)
Closed Access
Xue-Man Dong, Lin Chen, Yuxin Xu, et al.
Cancer Gene Therapy (2025)
Closed Access
LINC01305 and LAD1 Co‐Regulate CTTN and N‐WASP Phosphorylation, Mediating Cytoskeletal Reorganization to Promote ESCC Metastasis
Hang Yang, Rong Xiong, Ruolan Zhang, et al.
Molecular Carcinogenesis (2025)
Open Access
Hang Yang, Rong Xiong, Ruolan Zhang, et al.
Molecular Carcinogenesis (2025)
Open Access
Uncovering the role of microRNAs in esophageal cancer: from pathogenesis to clinical applications
Zhenglin He, Yanhong Ji, Yutong Yuan, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Zhenglin He, Yanhong Ji, Yutong Yuan, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
An optical coherence tomography study of a photoactive Pt(iv ) prodrug in oesophageal tissue
Huayun Shi, Muktesh Mohan, Kanwarpal Singh, et al.
RSC Advances (2025) Vol. 15, Iss. 5, pp. 3168-3171
Open Access
Huayun Shi, Muktesh Mohan, Kanwarpal Singh, et al.
RSC Advances (2025) Vol. 15, Iss. 5, pp. 3168-3171
Open Access
High mean corpuscular volume as a predictor of esophageal cancer: A cohort study based on the Japanese Shizuoka Kokuho Database
Shinsuke Sato, Emi Ohata, Eiji Nakatani, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0318791-e0318791
Open Access
Shinsuke Sato, Emi Ohata, Eiji Nakatani, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0318791-e0318791
Open Access
Integration of AI in Barrett’s Esophagus Clinical Practice: A New Way Forward
Justin Buttar, Hyun Jae Kim, Michael F. Byrne, et al.
AI in Precision Oncology (2025) Vol. 2, Iss. 1, pp. 19-32
Closed Access
Justin Buttar, Hyun Jae Kim, Michael F. Byrne, et al.
AI in Precision Oncology (2025) Vol. 2, Iss. 1, pp. 19-32
Closed Access
A nomogram for predicting cancer-specific survival in patients with locally advanced unresectable esophageal cancer: development and validation study
Liangyun Xie, Yafei Zhang, Xiedong Niu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Liangyun Xie, Yafei Zhang, Xiedong Niu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Developing a health education program for home enteral nutrition after esophageal cancer surgery based on the Delphi method
W. W. Tian, Wei Liu, Cuirong Wang, et al.
Medicine (2025) Vol. 104, Iss. 8, pp. e41586-e41586
Open Access
W. W. Tian, Wei Liu, Cuirong Wang, et al.
Medicine (2025) Vol. 104, Iss. 8, pp. e41586-e41586
Open Access
Catching cancer signals in the blood: Innovative pathways for early esophageal cancer diagnosis
Yue Zhao, Zhan Zhang, Jian-Hao Qiu, et al.
World Journal of Gastroenterology (2025) Vol. 31, Iss. 10
Closed Access
Yue Zhao, Zhan Zhang, Jian-Hao Qiu, et al.
World Journal of Gastroenterology (2025) Vol. 31, Iss. 10
Closed Access
The paths toward immunotherapy of esophageal cancer: An overview of clinical trials
Azfar Jamal, Allolo D Aldreiwish, Saeed Banawas, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114261-114261
Closed Access
Azfar Jamal, Allolo D Aldreiwish, Saeed Banawas, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114261-114261
Closed Access
SATB2 promotes radiation resistance of esophageal squamous cell carcinoma by regulating epithelial-to-mesenchymal transition via the Wnt/β-catenin pathway
Lin Chen, Youyi Wu, Yuchen Qian, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Lin Chen, Youyi Wu, Yuchen Qian, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Cell-based Immunotherapy in Esophageal Cancer
Masoud Lahouty, Amirhossein Soleymanzadeh, Sohrab Kazemi, et al.
Journal of drug targeting (2025), pp. 1-19
Closed Access
Masoud Lahouty, Amirhossein Soleymanzadeh, Sohrab Kazemi, et al.
Journal of drug targeting (2025), pp. 1-19
Closed Access
Neutrophil‐Lymphocyte Ratio May be Used as a Biomarker for Predicting Progression of Barrett's Esophagus to Esophageal Adenocarcinoma: A Retrospective Cohort Study
Zarian Prenatt, Het D. Patel, Naomi Reddy‐Patel, et al.
JGH Open (2025) Vol. 9, Iss. 3
Open Access
Zarian Prenatt, Het D. Patel, Naomi Reddy‐Patel, et al.
JGH Open (2025) Vol. 9, Iss. 3
Open Access
Multimodal deep learning for predicting PD-L1 biomarker and clinical immunotherapy outcomes of esophageal cancer
Hui Liu, Yuchen Bai, Zhidong Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Hui Liu, Yuchen Bai, Zhidong Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Global trends in esophageal cancer mortality with predictions to 2025, and in incidence by histotype
Claudia Santucci, Silvia Mignozzi, Matteo Malvezzi, et al.
Cancer Epidemiology (2023) Vol. 87, pp. 102486-102486
Closed Access | Times Cited: 11
Claudia Santucci, Silvia Mignozzi, Matteo Malvezzi, et al.
Cancer Epidemiology (2023) Vol. 87, pp. 102486-102486
Closed Access | Times Cited: 11
MicroRNAs: A novel signature in the metastasis of esophageal squamous cell carcinoma
Qi-Ying Wei, Feng Jin, Zhongyu Wang, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 11, pp. 1497-1523
Open Access | Times Cited: 3
Qi-Ying Wei, Feng Jin, Zhongyu Wang, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 11, pp. 1497-1523
Open Access | Times Cited: 3
Synergistic effects of Ω-3 polyunsaturated fatty acid supplementation and programmed cell death protein 1 blockade on tumor growth and immune modulation in a xenograft model of esophageal cancer
Xi Xiao, Shi‐Hong Luo, Jianbing Huang, et al.
Clinical Nutrition ESPEN (2024) Vol. 61, pp. 308-315
Closed Access | Times Cited: 3
Xi Xiao, Shi‐Hong Luo, Jianbing Huang, et al.
Clinical Nutrition ESPEN (2024) Vol. 61, pp. 308-315
Closed Access | Times Cited: 3